BridgeMD
New treatment option for Celiac Disease
Official title Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response?
ClinicalTrials.gov ID: NCT07039773
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the immune response to gluten in patients with celiac disease (CeD) by comparing different forms of gluten administration. The participant population includes adults diagnosed with CeD, who are adhering to a gluten-free diet (GFD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- BMI 18-33 kg/m2
- Willingness to comply with the study procedure and having signed informed, written consent
- Previous diagnosis of coeliac disease according to established guidelines based on positive serology (Endomysium test, IgA-TG2 and/or IgG-DGP)...
- Strict adherence to a gluten-free diet at least the 12 last months.
You likely can't join if
- Positive serology (IgA-TG2 below upper level of normal) at screening visit
- Pregnancy or breast feeding. Fertile women must use effective contraception.
- Other inflammatory disease like uncontrolled hypothyreosis, type 1 diabetes, cardiovascular diseases, thyroid and renal disorders, inflammatory bowel...
- Using of immunosuppressive/steroid medications
- Wheat allergy
- Severe acute infection
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.